Article Text

Download PDFPDF
BJO at a glance
  1. Creig Hoyt, Editor

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


    Choroidal neovascularisation associated with age related macular degeneration has been treated with photodynamic therapy (PDT) over the past few years. In many ways its efficacy has been disappointing. Moreover, it is expensive. Hopley and coworkers performed a cost utility analysis to estimate the cost effectiveness of PDT therapy involving different scenarios. This study concludes that PDT treatment is the only available treatment in some forms of neovascular age related macular degeneration. Therefore, PDT can be considered moderately cost effective for patients with reasonable visual acuity but considerably less cost effective for those with initial poor visual acuity. For an analysis of this study see the editorial by Brown and Brown. See pp 980 and 979


    Pterygium is a worldwide condition but with …

    View Full Text

    Linked Articles